Yaron Pereg is the founder of KAHR medical. KAHR medical has raised $110M in total funding. Latest round: Series A. Based in Jerusalem, Israel.
Yaron Pereg is the CEO of KAHR Medical, a Jerusalem-based clinical-stage oncology company. The company develops dual-targeting fusion proteins for cancer treatment, with its lead product, DSP107, in Phase I/II clinical studies in collaboration with Roche.
Full founder directory · Investor directory · Company funding database · Fundraising library